NCT01045369View on ClinicalTrials.gov

A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

June 30, 2011

Conditions
HIV Infections
Interventions
DRUG

Kaletra and Intelence Tablets

Kaletra 400 mg twice a day and Intelence Tablets 200mg twice a day.

Trial Locations (1)

77004

Therapeutic Concepts, PA, Houston

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

Tibotec, Inc

INDUSTRY

collaborator

BluKyne

UNKNOWN

lead

Therapeutic Concepts

OTHER